The Global Catheters Market

Table of Contents

Chapter- 1: INTRODUCTION -- Complimentary 3

• STUDY GOALS AND OBJECTIVES 1
• REASONS FOR DOING THE STUDY 1
• SCOPE OF REPORT 1
• METHODOLOGY 1
• INTENDED AUDIENCE 2
• INFORMATION SOURCES 2
• ANALYST CREDENTIALS 2
• RELATED REPORTS 2
• BCC ONLINE SERVICES 2
• DISCLAIMER 3

Chapter-2: SUMMARY 3

• SUMMARY 4
• SUMMARY TABLE GLOBAL CATHETER MARKET, THROUGH 2014 ($ MILLIONS) 5
• SUMMARY FIGURE GLOBAL CATHETER MARKET, 2008 AND 2014 (%) 6

Chapter-3: OVERVIEW OF GLOBAL CATHETER INDUSTRY 19

• ORIGINS 7
• CATHETER CONSTRUCTION 8
• CATHETER APPLICATIONS 8
• TYPES OF CATHETERS 9
• CARDIOVASCULAR CATHETERS 9
• Diagnostic Procedures and Cardiac Catheterization 10
• TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10
• TABLE 1 (CONTINUED) 11
• TABLE 2 TYPES OF CARDIAC CATHETERS 11
• Angiography Catheters 11
• Electrophysiology (EP) Catheters 12
• Percutaneous Coronary Intervention (PCI) Catheters 13
• TABLE 3 PTCA PROCEDURES 13
• Rapid Exchange PTCA Balloon Catheters 14
• Over - the-Wire PTCA Catheters 14
• Guiding Catheter 14
• UROLOGICAL CATHETERS 15
• Types of Urinary Catheterizations 16
• Intermittent Catheterization 16
• Indwelling Catheterization 16
• Suprapubic Catheterization 17
• Male External Condom Catheters 18
• NEUROVASCULAR CATHETERS 18
• INTRAVENOUS (IV) CATHETERS 19
• Single-Lumen Catheters 19
• Multi-Lumen Catheter 20
• Specialty IV Catheters 20
• Peripheral Vein Catheter 20
• Central Venous Catheter 20
• Peripherally Inserted Central Catheters (PICCs) 21
• TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 22
• SPECIALTY CATHETERS 22
• Thermodilution Catheters 22
• Suction Catheters 23
• Oximetry Catheters 23
• END-USER PREFERENCES 24
• SIZE OF CATHETER 24
• MATERIAL USED 24
• COATING 25
• DURATION OF CATHETER IN THE BODY 25
• INFECTION 25
• COST 25

Chapter-4: CATHETERS AND WORLD DEMOGRAPHICS 4

• TABLE 5 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2004 AND 2006* (THOUSANDS) 26
• WORLDWIDE PROCEDURES 27
• TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2008 (PER 100,000 POPULATION) 27
• WORLDWIDE ECONOMIC DEMOGRAPHICS 28
• TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1980 - 2005 (%) 28
• TABLE 7 (CONTINUED) 29
• WORLDWIDE POPULATION GROWTH 29

Chapter-5: CATHETER MATERIALS 7

• KEY CHARACTERISTICS OF CATHETER MATERIALS 30
• TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 30
• SURFACE CHARACTERISTICS 31
• RADIOPACITY 31
• COMPONENT MATERIALS 31
• LATEX 32
• SILICONE 32
• TEFLON (FLUOROPOLYMER) 33
• POLYURETHANE 33
• POLYVINYL CHLORIDE (PVC) 33
• POLYETHYLENE 33
• CATHETER COATINGS 34
• SILICONE ELASTOMER 34
• HYDROPHILIC COATING 34
• ANTIMICROBIAL COATING 35
• Silver Coating 35
• ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 35
• TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 36

Chapter-6: ANALYSIS OF THE GLOBAL CATHETER MARKET 26

• FACTORS INFLUENCING MARKET GROWTH 37
• FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 38
• DEMOGRAPHICS 38
• SURGICAL AND MEDICAL TRENDS 38
• Catheter Reuse 39
• REIMBURSEMENT 39
• EMERGING TECHNOLOGY 39
• PRODUCT DISTRIBUTION 40
• PURCHASING TRENDS 40
• TREATMENT COSTS 40
• LEADING MANUFACTURERS 41
• TABLE 10 REVENUES OF KEY CATHETER MANUFACTURERS, 2007 AND 2008 ($ MILLIONS) 41
• KEY MARKET DRIVERS 41
• INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 42
• INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND AIDS 42
• NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE 42
• INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS INCREASED SALES 42
• ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THE USE OF CATHETERS 43
• KEY MARKET RESTRAINTS 43
• PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES 43
• LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS 43
• REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCED CATHETERS 44
• EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICE TECHNOLOGIES 44
• GLOBAL CATHETER REVENUE ANALYSIS 44
• TABLE 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2014 ($ MILLIONS 45
• FIGURE 2 PROJECTED GLOBAL CATHETER MARKET, 2009 ($ MILLIONS) 45
• FIGURE 2 (CONTINUED) 46
• TABLE 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2008 AND 2014 (%) 47
• FIGURE 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2009 AND 2014 (%) 48
• MARKET SHARE FORECAST 49
• CONSEQUENCES OF THE 2008 ECONOMIC SLOWDOWN 49
• REVENUES, SHARES, AND PROJECTIONS BY REGION 50
• TABLE 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 50
• TABLE 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2008 AND 2014 (%) 51
• U.S. Catheter Market 51
• European Catheter Market 52
• Rest of the World Catheter Market 53
• REPROCESSED CATHETERS 54
• COMPETITIVE STRUCTURE 55
• TYPES OF COMPETITION 56
• TIERS OF COMPETITION 56
• MERGERS AND ACQUISITIONS 56
• TABLE 15 SELECTED KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER MARKET, 2008-2009 ($) 57
• END-USER GROUPS 57
• DISTRIBUTION STRUCTURE 58
• PURCHASE STRUCTURE 59
• COMPETITIVE FACTORS 59
• Regulatory Environment 59
• Pricing 59
• Catheter Properties 60
• Branding 60
• ANALYSIS OF THE GLOBAL CATHETER MARKET BASED ON STRENGTHS, OPPORTUNITIES, WEAKNESSES, AND THREATS 60
• STRENGTHS 60
• OPPORTUNITIES 61
• WEAKNESSES 61
• THREATS 62

Chapter-7: CARDIOVASCULAR CATHETERS 11

• KEY MARKET CHALLENGES 63
• CONTROVERSY REGARDING THE USE OF DRUG-ELUTING STENTS AFFECTS CATHETER USE 63
• PHARMACOLOGICAL APPROACHES ARE THREATENING CATHETER DEMAND 64
• LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BY PHYSICIANS 64
• KEY MARKET DRIVERS 64
• INCREASES IN THE INCIDENCE OF CARDIOVASCULAR DISEASES IS DRIVING THE NUMBER OF PROCEDURES 64
• POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO AN INCREASE IN THE USE OF CARDIAC CATHETERS 65
• ANGIOGRAPHY IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES 65
• INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN PHARMACEUTICAL-BASED THERAPIES 66
• KEY MARKET RESTRAINTS 66
• CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES 66
• DECREASE IN RESTENOSIS IS AFFECTING THE NUMBER OF STENT PROCEDURES PERFORMED 66
• CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES 67
• CARDIOVASCULAR CATHETER MARKET ANALYSIS 67
• TABLE 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, THROUGH 2014 ($ MILLIONS) 67
• FIGURE 4 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, 2014 ($ BILLIONS) 68
• ANGIOGRAPHY 69
• ELECTROPHYSIOLOGY/MAPPING CATHETERS 69
• BALLOON CATHETERS 69
• GUIDING CATHETERS 70
• INTRAVASCULAR ULTRASOUND CATHETERS 70
• TABLE 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE OF PROCEDURE, 2009 AND 2014 (%) 70
• FIGURE 5 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2009 AND 2014 (%) 71
• MARKET SHARES BY COMPANY 72
• TABLE 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%) 72
• FIGURE 6 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%) 72
• CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY 73
• COMPETITIVE STRUCTURE 73

Chapter-8: UROLOGY CATHETER MARKET 8

• KEY MARKET CHALLENGES 74
• USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLE CATHETERS 74
• USE OF CATHETERS HAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARY TRACT INFECTIONS (UTI) 74
• SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OF CLINICAL DATA 75
• KEY MARKET DRIVERS 75
• INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE 75
• CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USE OF CATHETERS 75
• SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENT ADOPTION 76
• KEY MARKET RESTRAINTS 76
• LENGTHY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVE ANTIMICROBIAL CATHETERS 76
• OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE 76
• UROLOGY CATHETER MARKET ANALYSIS 76
• TABLE 19 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH 2014 ($ MILLIONS) 77
• FIGURE 7 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2008-2014 ($ MILLIONS) 78
• MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER 78
• TABLE 20 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2008 AND 2014 (%) 79
• FIGURE 8 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2014 (%) 79
• Intermittent Catheters 79
• Foley Catheters 80
• Other Catheters 80
• MARKET SHARES BY COMPANY 80
• TABLE 21 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 81
• UROLOGY CATHETER PRODUCTS BY COMPANY 81
• COMPETITIVE STRUCTURE 81

Chapter-9: NEUROVASCULAR CATHETER MARKET 5

• KEY MARKET CHALLENGES 82
• COST OF SPECIALIZED MICROCATHETERS AFFECTS THEIR ADOPTION 82
• KEY MARKET DRIVERS 82
• ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS AND TREATMENT 82
• STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE 82
• NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURES AND INCREASING DEMAND 83
• MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS 83
• KEY MARKET RESTRAINTS 83
• INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITING NEUROCATHETER USE 83
• SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICAL PROCEDURES IS INFLUENCING NEUROCATHETER SALES 84
• MANY PATIENTS DIE BEFORE RECEIVING TREATMENT 84
• NEUROVASCULAR CATHETER MARKET ANALYSIS 84
• TABLE 22 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH 2014 ($ MILLIONS) 85
• MARKET SHARES BY COMPANY 85
• TABLE 23 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%) 86
• NEUROVASCULAR PRODUCTS, BY COMPANY 86
• COMPETITIVE STRUCTURE 86

Chapter-10: INTRAVENOUS CATHETER MARKET 6

• KEY MARKET CHALLENGES 87
• LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS 87
• MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION 87
• KEY MARKET DRIVERS 88
• STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES 88
• IV CATHETERS WITH ANTIMICROBIAL COATINGS IMPROVE THEIR MARKETABILITY 88
• INCREASED APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY BOOSTS IV CATHETER SALES 88
• KEY MARKET RESTRAINTS 89
• CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES 89
• REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS 89
• INTRAVENOUS CATHETER MARKET ANALYSIS 89
• TABLE 24 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2014 ($ MILLIONS) 89
• FIGURE 9 PROJECTED GLOBAL IV CATHETER MARKET, 2008-2014 ($ MILLIONS) 90
• MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 90
• TABLE 25 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2008 AND 2014 (%) 91
• MARKET SHARES BY COMPANY 91
• TABLE 26 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2008 (%) 92
• IV CATHETER PRODUCTS BY COMPANY 92
• COMPETITIVE STRUCTURE 92

Chapter-11: SPECIALTY CATHETERS 5

• KEY MARKET CHALLENGES 93
• LACK OF CLINICAL DATA TO SUPPORT EFFICACY 93
• KEY MARKET DRIVERS 93
• DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES 93
• THE EFFECTIVENESS OF SPECIALTY CATHETERS IS FUELING INTEREST BY MEDICAL STAFF AND PROMOTING THEIR USE 93
• KEY MARKET RESTRAINTS 94
• HIGH PRICE OF CATHETERS INHIBITS SALES 94
• LIMITED INTERNATIONAL EXPANSION DUE TO THE HIGHER COST OF SPECIALTY CATHETERS 94
• SPECIALTY CATHETER MARKET ANALYSIS 94
• TABLE 27 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2014 ($ MILLIONS) 94
• FIGURE 10 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2008-2014 ($ MILLIONS) 95
• MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 95
• TABLE 28 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE, 2008 AND 2014 (%) 96
• MARKET SHARES BY COMPANY 96
• TABLE 29 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 97
• SPECIALTY PRODUCTS BY COMPANY 97
• COMPETITIVE STRUCTURE 97

Chapter-12: GOVERNMENT REGULATIONS AND ISSUES 18

• CATHETER MARKET REGULATIONS 98
• CLASS I MEDICAL DEVICES 98
• CLASS II 98
• CLASS III 98
• TABLE 30 CATHETER TYPES AND CLASS 99
• TABLE 30 (CONTINUED) 100
• TABLE 30 (CONTINUED) 101
• FDA APPROVAL PROCESS 101
• PREMARKET NOTIFICATION 510(K) 102
• PREMARKET APPROVAL (PMA) 103
• INVESTIGATIONAL DEVICE EXEMPTION (IDE) 104
• ESTABLISHMENT REGISTRATION FORM 105
• MEDICAL DEVICE LISTING 105
• QUALITY SYSTEM (QS) REGULATION 106
• LABELING 107
• MEDICAL DEVICE REPORTING 107
• EUROPEAN HEALTHCARE STANDARDS 107
• REGULATORY DIRECTIVES 108
• The Active Implantable Medical Device Directive (AIMD) [90/385/EEC] 108
• The Medical Device Directive (MDD) [93/42/EEC] 108
• The In Vitro Medical Devices Directive (IVD) [98/79/EC] 108
• JAPANESE STANDARDS 109
• CHINESE STANDARDS 109
• INTERNATIONAL ORGANIZATION FOR STANDARDS (ISO) 110
• TABLE 31 CATHETER ISO NUMBERS 110
• DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS 110
• RECENT FDA 510(K) APPROVALS, EUROPEAN UNION CE APPROVALS, JAPANESE APPROVALS. 111
• TABLE 32 SELECTED U.S. FDA 510(K) APPROVALS, CE MARK APPROVAL, AND JAPANESE APPROVAL OF CATHETERS, 2007 - 2009 111
• TABLE 32 (CONTINUED) 112
• TABLE 32 (CONTINUED) 113
• FDA RECALLS 113
• MISLABELING 113
• NONSTERILE CONDITIONS 114
• MANUFACTURING DEFECTS/MALFUNCTIONS 114
• TABLE 33 U.S. CATHETER RECALLS IN 2008, 2009 114
• TABLE 33 (CONTINUED) 115

Chapter-13: PATENT ANALYSIS 11

• GLOBAL PATENT APPLICATIONS, 2008 AND 2009 116
• TABLE 34 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2009 117
• CATHETER PATENT ACTIVITY BY ASSIGNEE 117
• TABLE 35 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY 2007-JUNE 2009 (NUMBER OF PATENTS) 117
• TABLE 35 (CONTINUED) 118
• GLOBALLY ISSUED PATENTS, BY SEGMENT 118
• TABLE 36 GLOBAL PATENTS ISSUED, BY SEGMENT, 2008-2009 118
• TABLE 37 ISSUED CATHETER PATENT SHARES, BY SEGMENT, JANUARY 2007-JUNE 2009 (%) 119
• FIGURE 11 SHARE FOR ISSUED CATHETER PATENTS, BY SEGMENT, JANUARY 2007-JUNE 2009 (%) 119
• CARDIOVASCULAR CATHETER PATENTS 120
• TABLE 38 ISSUED CARDIOVASCULAR CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009 120
• FIGURE 12 ISSUED CARDIOVASCULAR CATHETER PATENTS, BY TYPE, MAY 2007-MAY 2009 (%) 120
• UROLOGY CATHETER PATENTS 121
• TABLE 39 ISSUED UROLOGY CATHETER PATENTS BY TYPE, JANUARY 2007-JUNE 2009 121
• IV CATHETER PATENTS 121
• TABLE 40 ISSUED IV CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009 122
• SPECIALTY CATHETER PATENTS 122
• NEUROVASCULAR 122
• MAJOR CATHETER PATENT RECIPIENTS FROM 1999 TO MAY 2009 122
• TABLE 41 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1999-MAY 2009 122
• TABLE 41 (CONTINUED) 123
• TABLE 41 (CONTINUED) 124
• FIGURE 13 PERCENT OF CATHETER PATENTS ISSUED TO TOP 10 MANUFACTURERS, 1999-MAY 2009 (%) 124
• FIGURE 13 (CONTINUED) 125
• CATHETER PATENT ACTIVITY BY COUNTRY 125
• TABLE 42 CATHETER PATENT ACTIVITY BY COUNTRY, JANUARY 2008-JUNE 2009 (NUMBER OF PATENTS FILED) 125
• TABLE 42 (CONTINUED) 126
• CONCLUSIONS OF THE PATENT ANALYSIS 126

Chapter-14: COMPANY PROFILES 39

• ABBOTT LABORATORIES 127
• TABLE 43 ABBOTT LABORATORIES' CATHETER PRODUCTS 127
• TABLE 43 (CONTINUED) 128
• ANGIODYNAMICS 128
• TABLE 44 ANGIODYNAMICS CATHETER PRODUCTS 129
• ARROW INTERNATIONAL (SEE TELEFLEX) 129
• ASTRA TECH, INC.-UROLOGY DIVISION 129
• TABLE 45 ASTRA TECH CATHETER PRODUCTS 130
• B BRAUN MELSUNGEN AG 130
• TABLE 46 B BRAUN CATHETER PRODUCTS 131
• BECTON DICKINSON & CO. 131
• TABLE 47 BD CATHETER PRODUCTS 132
• BOSTON SCIENTIFIC 132
• TABLE 48 BOSTON SCIENTIFIC CATHETER PRODUCTS 133
• TABLE 48 (CONTINUED) 134
• CARDINAL HEALTH 134
• TABLE 49 CARDINAL HEALTH CATHETER PRODUCTS 135
• COLOPLAST GROUP 135
• TABLE 50 COLOPLAST CATHETER PRODUCTS 136
• COOK MEDICAL 136
• TABLE 51 COOK MEDICAL CATHETER PRODUCTS 137
• TABLE 51 (CONTINUED) 138
• COVIDIEN (FORMERLY TYCO HEALTHCARE) 138
• TABLE 52 COVIDIEN CATHETER PRODUCTS 138
• TABLE 52 (CONTINUED) 139
• CR BARD 139
• TABLE 53 CR BARD CATHETER PRODUCTS 140
• TABLE 53 (CONTINUED) 141
• EDWARDS LIFESCIENCES 141
• TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 142
• EV3 ENDOVASCULAR, INC. 143
• TABLE 55 EV3 CATHETER PRODUCTS 143
• HOLLISTER 144
• TABLE 56 HOLLISTER CATHETER PRODUCTS 144
• HOSPIRA, INC. 144
• TABLE 57 HOSPIRA CATHETER PRODUCTS 145
• IRVINE BIOMEDICAL, INC. (SEE ST. JUDE MEDICAL) 145
• JOHNSON & JOHNSON 145
• TABLE 58 JOHNSON & JOHNSON CATHETER PRODUCTS 146
• TABLE 58 (CONTINUED) 147
• MEDTRONIC, INC. 147
• TABLE 59 MEDTRONIC CATHETER PRODUCTS 148
• MERIT MEDICAL SYSTEMS 148
• TABLE 60 MERIT MEDICAL CATHETER PRODUCTS 149
• ROCHESTER MEDICAL 149
• TABLE 61 ROCHESTER MEDICAL CATHETER PRODUCTS 150
• SMITHS MEDICAL 150
• TABLE 62 SMITHS MEDICAL CATHETER PRODUCTS 151
• TABLE 62 (CONTINUED) 152
• ST. JUDE MEDICAL 152
• TABLE 63 ST. JUDE MEDICAL CATHETER PRODUCTS 153
• TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 153
• TABLE 64 ARROW/TELEFLEX MEDICAL CATHETER PRODUCTS 154
• TABLE 64 (CONTINUED) 155
• TERUMO MEDICAL CORP. 155
• TABLE 65 TERUMO CORP. CATHETER PRODUCTS 156
• TABLE 65 (CONTINUED) 157
• TYCO HEALTHCARE (SEE COVIDIEN) 157
• VASCULAR SOLUTIONS 157
• TABLE 66 VASCULAR SOLUTIONS CATHETER PRODUCTS 157

APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 158

• TABLE 67 CATHETER PRODUCTS AND MANUFACTURERS 158
• TABLE 67 (CONTINUED) 159
• TABLE 67 (CONTINUED) 160
• TABLE 67 (CONTINUED) 161
• TABLE 67 (CONTINUED) 162
• TABLE 67 (CONTINUED) 163
• TABLE 67 (CONTINUED) 164
• TABLE 67 (CONTINUED) 165